α-Difluoromethylornithine (DFMO) as a Potent Arginase Activity Inhibitor in Human Colon Carcinoma Cells
- 15 April 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 55 (8), 1241-1245
- https://doi.org/10.1016/s0006-2952(97)00572-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Computer-aided comparison of the inhibition of arginase and nitric oxide synthase in macrophages by amino acids not related to arginineComparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 1996
- Metabolism of l-arginine through polyamine and nitric oxide synthase pathways in proliferative or differentiated human colon carcinoma cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995
- Rat Liver Arginase: Kinetic Mechanism, Alternate Substrates, and InhibitorsArchives of Biochemistry and Biophysics, 1994
- Multiple regulation of ornithine decarboxylase in enzyme-overproducing cellsBiochemical Journal, 1993
- Ornithine decarboxylase activity is critical for cell transformationNature, 1992
- Characterization of difluoromethylornithine-resistant mouse and human tumour cell linesBiochemical Journal, 1989
- POLYAMINESAnnual Review of Biochemistry, 1984
- Role of Polyamines in the Control of Cell Proliferation and DifferentiationDifferentiation, 1981
- Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogsJournal of the American Chemical Society, 1978
- Arginase Activity in Rat Small Intestinal MucosaActa Physiologica Scandinavica, 1973